Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Serine and Cognitive Retraining in Schizophrenia
NCT00237809Phase 3Completed
- Sponsor
- Yale University
- Start
- Sep 2002
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of d-serine in schizophrenia, schizoaffective disorder, sponsored by Yale University. Started Sep 2002; status: completed.
02
Drugs
d-serine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00237809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237809.